Literature DB >> 15998730

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Matthew I Bonaparte1, Antony S Dimitrov, Katharine N Bossart, Gary Crameri, Bruce A Mungall, Kimberly A Bishop, Vidita Choudhry, Dimiter S Dimitrov, Lin-Fa Wang, Bryan T Eaton, Christopher C Broder.   

Abstract

Hendra virus (HeV) and Nipah virus (NiV) belong to the genus Henipavirus of the family Paramyxoviridae and are unique in that they exhibit a broad species tropism and cause fatal disease in both animals and humans. They infect cells through a pH-independent membrane fusion process mediated by their fusion and attachment glycoproteins. Previously, we demonstrated identical cell fusion tropisms for HeV and NiV and the protease-sensitive nature of their unknown cell receptor and identified a human cell line (HeLa-USU) that was nonpermissive for fusion and virus infection. Here, a microarray analysis was performed on the HeLa-USU cells, permissive HeLa-CCL2 cells, and two other permissive human cell lines. From this analysis, we identified a list of genes encoding known and predicted plasma membrane surface-expressed proteins that were highly expressed in all permissive cells and absent from the HeLa-USU cells and rank-ordered them based on their relative levels. Available expression vectors containing the first 10 genes were obtained and individually transfected into HeLa-USU cells. One clone, encoding human ephrin-B2 (EFNB2), was found capable of rendering HeLa-USU cells permissive for HeV- and NiV-mediated cell fusion as well as infection by live virus. A soluble recombinant EFNB2 could potently block fusion and infection and bind soluble recombinant HeV and NiV attachment glycoproteins with high affinity. Together, these data indicate that EFNB2 serves as a functional receptor for both HeV and NiV. The highly conserved nature of EFNB2 in humans and animals is consistent with the broad tropism exhibited by these emerging zoonotic viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998730      PMCID: PMC1169237          DOI: 10.1073/pnas.0504887102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Structural basis for paramyxovirus-mediated membrane fusion.

Authors:  K A Baker; R E Dutch; R A Lamb; T S Jardetzky
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

2.  Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion.

Authors:  C J Russell; T S Jardetzky; R A Lamb
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

3.  Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.

Authors:  J P Langedijk; F J Daus; J T van Oirschot
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  The attachment protein of Hendra virus has high structural similarity but limited primary sequence homology compared with viruses in the genus Paramyxovirus.

Authors:  M Yu; E Hansson; J P Langedijk; B T Eaton; L F Wang
Journal:  Virology       Date:  1998-11-25       Impact factor: 3.616

5.  A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals.

Authors:  L F Wang; W P Michalski; M Yu; L I Pritchard; G Crameri; B Shiell; B T Eaton
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Susceptibility of cats to equine morbillivirus.

Authors:  H A Westbury; P T Hooper; S L Brouwer; P W Selleck
Journal:  Aust Vet J       Date:  1996-08       Impact factor: 1.281

7.  The lesions of experimental equine morbillivirus disease in cats and guinea pigs.

Authors:  P T Hooper; H A Westbury; G M Russell
Journal:  Vet Pathol       Date:  1997-07       Impact factor: 2.221

8.  Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats.

Authors:  M M Williamson; P T Hooper; P W Selleck; L J Gleeson; P W Daniels; H A Westbury; P K Murray
Journal:  Aust Vet J       Date:  1998-12       Impact factor: 1.281

9.  Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

Authors:  O Nussbaum; C C Broder; E A Berger
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Functional and structural interactions between measles virus hemagglutinin and CD46.

Authors:  O Nussbaum; C C Broder; B Moss; L B Stern; S Rozenblatt; E A Berger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  201 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

3.  Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion.

Authors:  Nadine Ader; Melinda A Brindley; Mislay Avila; Francesco C Origgi; Johannes P M Langedijk; Claes Örvell; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

4.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

5.  Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment.

Authors:  Sandra Diederich; Lucie Sauerhering; Michael Weis; Hermann Altmeppen; Norbert Schaschke; Thomas Reinheckel; Stephanie Erbar; Andrea Maisner
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.

Authors:  Sarah A Connolly; George P Leser; Hsien-Shen Yin; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

8.  Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation.

Authors:  Shannon D Whitman; Rebecca Ellis Dutch
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

9.  A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Yan-Ru Feng; Karla A Fenton; Katharine N Bossart; Lianying Yan; Yee-Peng Chan; Christopher C Broder; Thomas W Geisbert
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 10.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.